Pro Retina Stiftung

Stiftung zur Verhütung von Blindheit

Service-Navigation
 
Inhalt

RETINAL DEGENERATION

Genes, Progression, Therapy

Friday, March 30th 2007

13:00-13:05 Franz Badura: Welcome and opening remarks

13:05-13:15 Rainald von Gizycki: “The patient’s view in times of scientific progress”

13:15-13:30 Eberhart Zrenner: “Retinal degeneration – genes, progression, therapy”

13:30-15:10 Session 1: Stationary diseases of the retina

  1. Birgit Lorenz, Regensburg: “The clinics of stationary retinal disease”
  2. Alexandra Koschak, Innsbruck: “Functional consequences of Ca(v)1.4 L-type Ca2+ channel mutations”
  3. Christina Zeitz, Zürich: “Gene mutations leading to stationary or progressive defects in retinal signal transmission”
  4. Peggy Reuter, Tübingen: “Functional analyses of mutant cone CNG channels”

15:10-15:45 Coffee break

15:45-17:25 Session 2: Gene/protein networks in retinal degeneration

  1. Christian A. Hübner, Hamburg: “RDH12 and visual function”
  2. Ronald Wanders, Amsterdam: “Molecular basis of Refsum disease”
  3. Nicholas Katsanis, Baltimore: “Protein networks in Bardet-Biedl syndrome”
  4. Bastian Linder, Würzburg: “Defects in splicing as a possible cause of Retinitis Pigmentosa”

18:30 Dinner

19:30 Poster session and “swinging” discussions

Saturday, March 31st 2007

08:30-10:10 Session 3: Systemic disease and mouse models for retinal degeneration

  1. Muriel Auberson, Berlin: “Retinal degeneration in CLC knockout mouse models”
  2. Stefan Storch, Hamburg: “Retinal degeneration in lysosomal storage diseases”
  3. Andreas Feigenspan, Oldenburg: PKC – a ubiquitously expressed enzyme with crucial relevance for retinal function”
  4. Tanya Tolmachova, London: “Retinal degeneration in choroideremia mouse models”

10:10-10:45 Coffee break

10:45-12:25 Session 4: Approaches to therapy

  1. Naomi Chadderton, Dublin: “Strategies for therapeuticl approaches in dominantly inherited retinopathies”
  2. Marius Ader, Dublin “Toward a RNAi-based gene therapy in dominant retinitis pigmentosa”
  3. Marijana Samardzija, Zürich: “Rpe65-R91W knock-in mice: pathophysiology and consequences for therapy”
  4. Stefan Linke, Hamburg: “Stem cell-based therapeutic approaches to retinal disease”

12:25-13:00 Poster awards and short presentations

13:00 Lunch and end of meeting

Aktuelles

Bitte unterstützen Sie unsere Arbeit mit Ihrer Spende!

Jeder Euro hilft. Weitere Informationen finden Sie auf der Seite: Spenden an die Pro-Retina-Stiftung

Newsletter

Abonnieren Sie unseren Newsletter PRO RETINA News!


© 2010 - 2017 - PRO RETINA-Stiftung zur Verhütung von Blindheit

Datenschutzerklärung